New Results

Host Chitinase 3-like-1 is a Universal Therapeutic Target for the Delta, Omicron and Other SARS-CoV-2 Viral Variants in COVID 19

Suchitra Kamle, Bing Ma, Chang Min Lee, Gail Schor, Chun Geun Lee, Jack A. Elias
doi: https://doi.org/10.1101/2022.01.21.477274

Article Information

doi 
https://doi.org/10.1101/2022.01.21.477274
History 
  • January 24, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Suchitra Kamle1,
  2. Bing Ma1,
  3. Chang Min Lee1,
  4. Gail Schor1,
  5. Chun Geun Lee1 and
  6. Jack A. Elias1,2,#
  1. 1Molecular Microbiology and Immunology, Brown University 185 Meeting St. Providence, RI. 02912, USA
  2. 2Department of Medicine Brown University Providence, RI 02912, USA
  1. ↵#corresponding author: jack_elias{at}brown.edu

  1. Author Contributions Conception and design: SK, JAE, CGL; Generation of experimental resources and data collection: SK, BM, CML, GS; Analysis and interpretation: SK, CGL, JAE; Drafting the manuscript for important intellectual content: JAE, CGL, SK.

Back to top
Posted January 24, 2022.
Download PDF

Supplementary Material

Email
Host Chitinase 3-like-1 is a Universal Therapeutic Target for the Delta, Omicron and Other SARS-CoV-2 Viral Variants in COVID 19
Suchitra Kamle, Bing Ma, Chang Min Lee, Gail Schor, Chun Geun Lee, Jack A. Elias
bioRxiv 2022.01.21.477274; doi: https://doi.org/10.1101/2022.01.21.477274
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area